NCT03725618View on ClinicalTrials.gov

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

PHASE4CompletedINTERVENTIONAL

Enrollment

1,788

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

Yellow Fever

Interventions

BIOLOGICAL

Yellow Fever 17DD Vaccine

live attenuated vaccine based on the 17DD strain

Trial Locations (1)

30333

Centers for Disease Control and Prevention, Atlanta

All Listed Sponsors

collaborator

Infectious Disease Institute, Kampala, Uganda

OTHER

collaborator

MRC/UVRI and LSHTM Uganda Research Unit

OTHER

collaborator

Ministry of Health, Uganda

OTHER_GOV

lead

Centers for Disease Control and Prevention

FED

NCT03725618 - Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old | Biotech Hunter | Biotech Hunter